These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2754707)

  • 1. 9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.
    Shutske GM; Pierrat FA; Kapples KJ; Cornfeldt ML; Szewczak MR; Huger FP; Bores GM; Haroutunian V; Davis KL
    J Med Chem; 1989 Aug; 32(8):1805-13. PubMed ID: 2754707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.
    Shutske GM; Pierrat FA; Cornfeldt ML; Szewczak MR; Huger FP; Bores GM; Haroutunian V; Davis KL
    J Med Chem; 1988 Jul; 31(7):1278-9. PubMed ID: 3385720
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential neurotoxicity of a novel aminoacridine analogue.
    Walker TM; Starr B; Dewhurst BB; Atterwill C
    Hum Exp Toxicol; 1995 Jun; 14(6):469-74. PubMed ID: 8519521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
    Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J
    Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine-new tacrine derivate with cholinergic properties.
    Korabecny J; Musilek K; Zemek F; Horova A; Holas O; Nepovimova E; Opletalova V; Hroudova J; Fisar Z; Jung YS; Kuca K
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6563-6. PubMed ID: 21920739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.
    Smith CP; Bores GM; Petko W; Li M; Selk DE; Rush DK; Camacho F; Winslow JT; Fishkin R; Cunningham DM; Brooks KM; Roehr J; Hartman HB; Davis L; Vargas HM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):710-20. PubMed ID: 9023283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates.
    Fang L; Appenroth D; Decker M; Kiehntopf M; Roegler C; Deufel T; Fleck C; Peng S; Zhang Y; Lehmann J
    J Med Chem; 2008 Feb; 51(4):713-6. PubMed ID: 18232655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatment.
    Korabecny J; Musilek K; Holas O; Nepovimova E; Jun D; Zemek F; Opletalova V; Patocka J; Dohnal V; Nachon F; Hroudova J; Fisar Z; Kuca K
    Molecules; 2010 Dec; 15(12):8804-12. PubMed ID: 21127466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
    El-Malah A; Gedawy EM; Kassab AE; Salam RM
    Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
    Fernández-Bachiller MI; Pérez C; Monjas L; Rademann J; Rodríguez-Franco MI
    J Med Chem; 2012 Feb; 55(3):1303-17. PubMed ID: 22243648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted Aminobenzothiazole Derivatives of Tacrine: Synthesis and Study on Learning and Memory Impairment in Scopolamine-Induced Model of Amnesia in Rat.
    Ahmadi A; Roghani M; Noori S; Nahri-Niknafs B
    Mini Rev Med Chem; 2019; 19(1):72-78. PubMed ID: 30009706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
    Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Asatouri R; Vafadarnejad F; Moghadam FH; Khanavi M; Sharifzadeh M; Akbarzadeh T
    Eur J Med Chem; 2017 Jan; 125():1200-1212. PubMed ID: 27863370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Li SY; Jiang N; Xie SS; Wang KD; Wang XB; Kong LY
    Org Biomol Chem; 2014 Feb; 12(5):801-14. PubMed ID: 24310227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
    Muñoz-Ruiz P; Rubio L; García-Palomero E; Dorronsoro I; del Monte-Millán M; Valenzuela R; Usán P; de Austria C; Bartolini M; Andrisano V; Bidon-Chanal A; Orozco M; Luque FJ; Medina M; Martínez A
    J Med Chem; 2005 Nov; 48(23):7223-33. PubMed ID: 16279781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes.
    Nielsen JA; Mena EE; Williams IH; Nocerini MR; Liston D
    Eur J Pharmacol; 1989 Nov; 173(1):53-64. PubMed ID: 2606156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease.
    Fink DM; Bores GM; Effland RC; Huger FP; Kurys BE; Rush DK; Selk DE
    J Med Chem; 1995 Sep; 38(18):3645-51. PubMed ID: 7658452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Velnacrine thiaanalogues as potential agents for treating Alzheimer's disease.
    Tabarrini O; Cecchetti V; Temperini A; Filipponi E; Lamperti MG; Fravolini A
    Bioorg Med Chem; 2001 Nov; 9(11):2921-8. PubMed ID: 11597473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease.
    Oset-Gasque MJ; González MP; Pérez-Peña J; García-Font N; Romero A; del Pino J; Ramos E; Hadjipavlou-Litina D; Soriano E; Chioua M; Samadi A; Raghuvanshi DS; Singh KN; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 74():491-501. PubMed ID: 24502897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase inhibition in the scopolamine model of dementia.
    Wesnes KA; Simpson PM; White L; Pinker S; Jertz G; Murphy M; Siegfried K
    Ann N Y Acad Sci; 1991; 640():268-71. PubMed ID: 1776749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.